Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models-Reference-Cited by-同舟云学术

Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models

Published:2020-01-01 Issue:1 Volume:9 Page:2606-2618
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Wang Ze-Jun¹²,Zhang Hua-Jun³,Lu Jia¹²,Xu Kang-Wei⁴,Peng Cheng³,Guo Jing¹²,Gao Xiao-Xiao³,Wan Xin¹²,Wang Wen-Hui¹²,Shan Chao³,Zhang Su-Cai⁵,Wu Jie¹²,Yang An-Na¹²,Zhu Yan³,Xiao Ao¹²,Zhang Lei³,Fu Lie¹²,Si Hao-Rui³,Cai Qian¹²,Yang Xing-Lou³,You Lei¹²,Zhou Yan-Ping¹²,Liu Jing¹²,Pang De-Qing¹²,Jin Wei-Ping¹²,Zhang Xiao-Yu¹²,Meng Sheng-Li¹²,Sun Yun-Xia⁵,Desselberger Ulrich⁶,Wang Jun-Zhi⁴,Li Xin-Guo¹²,Duan Kai¹²,Li Chang-Gui⁴,Xu Miao⁴,Shi Zheng-Li³^ORCID,Yuan Zhi-Ming³,Yang Xiao-Ming²⁷,Shen Shuo¹²^ORCID

Affiliation:

1. Wuhan Institute of Biological Products Co. Ltd., Wuhan, People’s Republic of China

2. National Engineering Technology Research Center of Combined Vaccines, Wuhan, People’s Republic of China

3. Center for Biosafety Mega-Science, Chinese Academy of Sciences, CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Wuhan, People’s Republic of China

4. National Institutes for Food and Drug Control, Beijing, People’s Republic of China

5. JOINN Laboratories (Beijing), Beijing, People’s Republic of China

6. Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK

7. China National Biotec Group Company Ltd, Beijing, People’s Republic of China

Funder

Department of Biotechnology, Ministry of Science and Technology, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1852059